Identification of differentially expressed proteins in chemotherapy- sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods

Medical Oncology

Volumn 30, Issue 2, 2013, Pages

  Liu, Yiping ^a   Zeng, Liang ^b   Zhang, Shusheng ^c   Zeng, Shan ^a   Huang, Jin ^a   Tang, Youhong ^a   Zhong, Meizuo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c The Eighth Hospital of Changsha   (China)

Author keywords

Chemoresistance; Chemosensitivity; CHOP chemotherapy; Differential expression; Diffuse large B cell lymphoma; Proteomics

Indexed keywords

14 3 3 PROTEIN EPSILON; 14 KDA PHOSPHOHISTIDINE PHOSPHATASE ISOFORM 3; 3 HYDROXYACYL COA DEHYDROGENASE TYPE 2 ISOFORM 1; 3 HYDROXYACYL COENZYME A DEHYDROGENASE; 6 PHOSPHOGLUCONOLACTONASE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CALGRANULIN B; COLLAGEN TYPE 6; CORONIN LIKE PROTEIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EZRIN; FERRITIN; GLUCONOLACTONASE; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN BETA 1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H3 ISOFORM A; HISTONE H2A; HUMAN RAB GDP DISSOCIATION INHIBITOR; LIPOCORTIN 5; MEDIUM TUMOR ANTIGEN ASSOCIATED 61 KD PROTEIN; PLECKSTRIN; PRE MRNA PROCESSING FACTOR 19; PREDNISONE; PROTEIN 14 3 3; TUMOR PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOSENSITIVITY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LARGE CELL LYMPHOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIDRUG RESISTANCE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; COMPARATIVE STUDY; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; TUMOR CELL CULTURE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISONE; PROTEOMICS; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 84874943010     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0528-5     Document Type: Article

References (21)

1. Cultrera JL, Dalia SM. Diffuse large B-cell lymphoma: current strategies and future directions. Cancer Control. 2012;19:204-13.
2. Nedomova R, Papajik T, Prochazka V, Indrak K, Jarosova M. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL). Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012; doi: 10.5507/bp.2012.085.
3. Maxwell SA, Li Z, Jaya D, Ballard S, Ferrell J, Fu H. 14-3-3 epsilon mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen. J Biol Chem. 2009;284:22379-89.
4. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8:68-74.
5. Chance MR, Chang J, Liu S, Gokulrangan G, Chen DH, Lindsay A, Geng R, Zheng QY, Alagramam K. Proteomics, bioinformatics and targeted gene expression analysis reveals up-regulation of cochlin and identifies other potential biomarkers in the mouse model for deafness in Usher syndrome type 1F. Hum Mol Genet. 2010;19:1515-27.
6. Bortner JD, Richie JP, Das A, Liao J, Umstead TM, Stanley A, Stanley BA, Belani CP, El-Bayoumy K. Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. J Proteome Res. 2011;10:1151-9.
7. Liu Y, Teng X, Yang X, Song Q, Lu R, Xiong J, Liu B, Zeng N, Zeng Y, Long J, Cao R, Lin Y, He Q, Chen P, Lu M, Liang S. Shotgun proteomics and network analysis between plasma membrane and extracellular matrix proteins from rat olfactory ensheathing cells. Cell Transpl. 2010;19:133-46.
8. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-López A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol. 1999;17:1244-53.
9. Zhu H, Pei HP, Zeng S, Chen J, Shen LF, Zhong MZ, Yao RJ, Shen H. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma. J Proteome Res. 2009;8:3969-76.
10. Lv XG, Ji MY, Dong WG, Lei XF, Liu M, Guo XF, Wang J, Fang C. EBP50 gene transfection promotes 5-fluorouracil-induced apoptosis in gastric cancer cells through Bax- and Bcl-2-triggered mitochondrial pathways. Mol Med Report. 2012;5:1220-6.
11. Fan NJ, Gao CF, Wang CS, Zhao G, Lv JJ, Wang XL, Chu GH, Yin J, Li DH, Chen X, Yuan XT, Meng NL. Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method. J Proteomics. 2012;75:3977-86.
12. Pyo JS, Roh SH, Kim DK, Lee JG, Lee YY, Hong SS, Kwon SW, Park JH. Anti-cancer effect of Betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2 D SDS PAGE coupled with nano-HPLC tandem Mass Spectrometry. Planta Med. 2009;75:127-31.
13. Wu K, Wang X, Xie Z, Liu Z, Lu Y. Glutathione S-transferase P1 gene polymorphism and bladder cancer susceptibility: an updated analysis. Mol Biol Rep. 2013;40:687-95.
14. Vasiljević N, Ahmad AS, Beesley C, Thorat MA, Fisher G, Berney DM, Møller H, Yu Y, Lu YJ, Cuzick J, Foster CS, Lorincz AT. Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer. Prostate Cancer Prostatic Dis. 2012;. doi: 10.1038/pcan.2012.47.
15. Tang S, Huang W, Zhong M, Yin L, Jiang H, Hou S, Gan P, Yuan Y. Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines. J Proteomics. 2012;75:2352-60.
16. Guo JP, Coppola D, Cheng JQ. IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation. J Biol Chem. 2011;286:37389-98.
17. Okada S, Suzuki K, Takaharu K, Noda H, Kamiyama H, Maeda T, Saito M, Koizumi K, Miyaki Y, Konishi F. Aberrant methylation of the pleckstrin and Sec7 domain-containing gene is implicated in ulcerative colitis-associated carcinogenesis through its inhibitory effect on apoptosis. Int J Oncol. 2012;40:686-94.
18. Borst P, Jonkers J, Rottenberg S. What makes tumor multidrug resistance? Cell Cycle. 2007;6:2782-7.
19. Backos DS, Franklin CC, Reigan P. The role of glutathione in brain tumor drug resistance. Biochem Pharmacol. 2012;83:1005-12.
20. Romero A, Martín M, Oliva B, de la Torre J, Furio V, de la Hoya M, García-Sáenz JA, Moreno A, Román JM, Diaz-Rubio E, Caldés T. Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients. Ann Oncol. 2012;23:1750-6.
21. Wang YC, Yo YT, Lee HY, Liao YP, Chao TK, Su PH, Lai HC. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome. Am J Pathol. 2012;180:1159-69.